DE3236298A1 - Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten - Google Patents

Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten

Info

Publication number
DE3236298A1
DE3236298A1 DE19823236298 DE3236298A DE3236298A1 DE 3236298 A1 DE3236298 A1 DE 3236298A1 DE 19823236298 DE19823236298 DE 19823236298 DE 3236298 A DE3236298 A DE 3236298A DE 3236298 A1 DE3236298 A1 DE 3236298A1
Authority
DE
Germany
Prior art keywords
lectin
glyco
cancer
gra
related antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19823236298
Other languages
German (de)
English (en)
Other versions
DE3236298C2 (enExample
Inventor
Masakazu Takasaki Gunma Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56156413A external-priority patent/JPS5857318A/ja
Priority claimed from JP15641481A external-priority patent/JPS5857321A/ja
Priority claimed from JP56158473A external-priority patent/JPS5859923A/ja
Priority claimed from JP56158472A external-priority patent/JPS5859922A/ja
Priority claimed from JP57111168A external-priority patent/JPS591420A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE3236298A1 publication Critical patent/DE3236298A1/de
Application granted granted Critical
Publication of DE3236298C2 publication Critical patent/DE3236298C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE19823236298 1981-10-01 1982-09-30 Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten Granted DE3236298A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP56156413A JPS5857318A (ja) 1981-10-01 1981-10-01 癌細胞障害性リンパ球の製造法
JP15641481A JPS5857321A (ja) 1981-10-01 1981-10-01 抗癌剤
JP56158473A JPS5859923A (ja) 1981-10-05 1981-10-05 抗癌剤
JP56158472A JPS5859922A (ja) 1981-10-05 1981-10-05 癌細胞障害性リンパ球
JP57111168A JPS591420A (ja) 1982-06-28 1982-06-28 糖鎖関連抗原およびその製造法

Publications (2)

Publication Number Publication Date
DE3236298A1 true DE3236298A1 (de) 1984-03-15
DE3236298C2 DE3236298C2 (enExample) 1987-09-24

Family

ID=27526479

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19823236298 Granted DE3236298A1 (de) 1981-10-01 1982-09-30 Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten
DE19823249568 Granted DE3249568A1 (de) 1981-10-01 1982-09-30 Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19823249568 Granted DE3249568A1 (de) 1981-10-01 1982-09-30 Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs

Country Status (19)

Country Link
AR (1) AR230731A1 (enExample)
AT (2) AT382080B (enExample)
AU (1) AU554858B2 (enExample)
BE (1) BE893704A (enExample)
CA (1) CA1195269A (enExample)
CH (2) CH655660B (enExample)
DD (2) DD209577A5 (enExample)
DE (2) DE3236298A1 (enExample)
DK (1) DK292182A (enExample)
FI (1) FI77157C (enExample)
FR (1) FR2513882B1 (enExample)
IL (1) IL66270A (enExample)
IT (1) IT1189305B (enExample)
MX (1) MX7437E (enExample)
NL (1) NL8202638A (enExample)
NO (1) NO161601C (enExample)
NZ (1) NZ201112A (enExample)
PT (1) PT75148B (enExample)
SE (1) SE8204058L (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (de) * 1969-08-28 1971-03-04 Stiftung Onophrio Heilmittel mit proliferationshemmender Wirkung und Verfahren zur Herstellung dieses Heilmittels
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Biochem.Biophys.Res.Comm., 62, 144, 1975, 89, 448-455, 1979, 96, 1547-1553, 1980
Biochemistry, 13, 196-204, 1974
Br.J.Exp.Pathol., 27, 228-236, 1946
Carbohydrate Research, 51, 107-118, 1976
Cell, 18, 183-191, 1979
J.B.C., 250, 8518-8523, 1975
J.Biochem., 89, 473-481, 1981
MEYER: Enzyklopädisches Lexikon, Bd. 21, 1977, S. 589 *
Proc.Nat.Acad.Sci., 75, 2215-2219, 1978
Z.Immunitätsforsch., 138, 423-433, 1966

Also Published As

Publication number Publication date
ATA363782A (de) 1986-06-15
NL8202638A (nl) 1983-05-02
CA1195269A (en) 1985-10-15
NO161601B (no) 1989-05-29
FR2513882A1 (fr) 1983-04-08
SE8204058L (sv) 1983-04-02
IT1189305B (it) 1988-02-04
DE3249568A1 (de) 1985-02-07
IL66270A (en) 1986-03-31
NO161601C (no) 1989-09-06
CH655661B (enExample) 1986-05-15
FI77157C (fi) 1989-02-10
CH655660B (enExample) 1986-05-15
IT8248724A0 (it) 1982-06-30
FI77157B (fi) 1988-10-31
ATA354585A (de) 1989-08-15
DD209577A5 (de) 1984-05-16
DD221917A5 (de) 1985-05-08
IL66270A0 (en) 1982-11-30
DK292182A (da) 1983-04-02
IT8248724A1 (it) 1983-12-30
PT75148B (en) 1986-08-14
AU8545882A (en) 1983-04-14
BE893704A (fr) 1982-10-18
DE3236298C2 (enExample) 1987-09-24
FI822325L (fi) 1983-04-02
FR2513882B1 (fr) 1986-04-04
MX7437E (es) 1988-11-14
DE3249568C2 (enExample) 1987-10-01
AT390002B (de) 1990-03-12
AR230731A1 (es) 1984-06-29
NZ201112A (en) 1986-10-08
FI822325A0 (fi) 1982-06-29
SE8204058D0 (sv) 1982-06-30
AU554858B2 (en) 1986-09-04
PT75148A (en) 1982-07-01
AT382080B (de) 1987-01-12
NO822215L (no) 1983-04-05

Similar Documents

Publication Publication Date Title
DE69125735T2 (de) Verfahren zur Aktivierung der zytolytischen Wirkung von Lymphozyten unter Verwendung von anti-CD28-Antikörper
DE3686927T2 (de) Neovaskularisierungsinhibitoren und deren herstellung.
DE68920656T2 (de) Verwendung vpn Adenosin-5'-phosphate in der Behandlung von Krebscachexia.
DE3227262A1 (de) Verfahren zur herstellung von target-zellen-lysis-faktor und dessen verwendung
CH678492A5 (enExample)
DE3042117A1 (de) Gynosaponine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE69110060T2 (de) In der humantherapie nützliche substanzen peptidischer natur.
US6051613A (en) Nitrogen monoxide production suppressor
DE19541284A1 (de) Verfahren zur Immunmodulation
GB2082066A (en) Neem bark extracts possessing antineoplastic activities
DE69627780T2 (de) Peptid das eine Immunantwort gegen menschlichen Magenkrebs induziert und Arzneimittel die es enthält zur Vorbeugung oder Behandlung von Magenkrebs
DE69014543T2 (de) Multivalentes immunogen lmi.
US20050287230A1 (en) Method of producing ginsenoside 20 (R)-Rh2 and composition of matter thereof
佐々木琢磨 et al. Antitumor activity and immunomodulatory effect of glycoprotein fraction from scallop Patinopecten yessoensis.
GB2106935A (en) Cancer cell-combatting lymphocytes process, for the production thereof, and anticancer agents containing said lymphocytes
DE3418820A1 (de) Arzneimittel fuer verdauungsgeschwuer
DE3236298A1 (de) Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten
DE4138624C2 (enExample)
DE69527640T2 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
DE69712907T2 (de) Immunogene tlp-zusammensetzung
CH650154A5 (de) Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung.
EP0019167B1 (de) Arzneipräparat zur Behandlung von Carcinomen und Verfahren zu dessen Herstellung
CA1201988A (en) Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes
DE4204132C2 (de) Aufbereitung für die Gewinnung von Vakzinen für eine Immuntherapie
KR100209180B1 (ko) 아세만난을 포함하는 약제학적 조성물

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
AH Division in

Ref country code: DE

Ref document number: 3249568

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 3249568

Format of ref document f/p: P

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 3249568

Format of ref document f/p: P

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee